electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [08/19/2026 13:20 PDT] electroCore, Inc. (NASDAQ:ECOR), Up By 100% ($8.96) From $8.96 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [08/18/2026 06:07 PDT] ECOR, Expected to Trade Higher After Bullish Insider Trading
• [08/11/2026 07:02 PDT] ECOR Expected to Trade Up After Bullish Patterns Develop
• [08/07/2026 11:45 PDT] electroCore, Inc. (NASDAQ:ECOR), Up By 100% ($6.56) From $6.56 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [07/23/2026 06:38 PDT] ECOR Expected to Trade Up After Bullish Patterns Develop
• [07/14/2026 06:55 PDT] ECOR Expected to Trade Up After Bullish Patterns Develop
• [07/13/2026 06:30 PDT] ECOR Expected to Trade Up After Bullish Patterns Develop
• [07/06/2026 11:07 PDT] electroCore, Inc. (NASDAQ:ECOR), Up By 100% ($7.84) From $7.84 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [06/30/2026 07:46 PDT] ECOR Expected to Trade Up After Bullish Patterns Develop
• [06/29/2026 06:11 PDT] ECOR Expected to Trade Up After Bullish Patterns Develop